Advertisement

Reactions Weekly

, Volume 1781, Issue 1, pp 101–101 | Cite as

Certolizumab pegol

Various toxicities: 17 case reports
Case report
  • 11 Downloads

Reference

  1. Torrente-Segarra V, et al. RENACER study: Assessment of 12-month efficacy and safety of 168 certolizumab PEGol rheumatoid arthritis-treated patients from a Spanish multicenter national database. Modern rheumatology / the Japan Rheumatism Association 26: 336-341, No. 3, May 2016. Available from: URL: http://doi.org/10.3109/14397595.2015.1101200 - SpainCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations